INJEX Pharma AG Announces Initial Shipment of INJEX30 Syringes Without a Needle to Canada  
8/14/2012 9:57:36 AM

BERLIN--(BUSINESS WIRE)--Medical Marketing Canada (MMC) Inc. is pleased to announce it has successfully navigated the complex registration process for INJEX 30 in Canada. INJEX Pharma AG and their exclusive international partners continue to enter new countries via national registrations in numerous countries including China and India which offer significant growth opportunities for this innovative technology while delivering solutions to help improve the quality of life.